Cytochrome P450 2C8/9/18/19 Blocking Peptide
The peptide is used to block Anti-Cytochrome P450 2C8/9/18/19 Antibody (#CPA6140) reactivity.
| Supplier | Cohesion Biosciences |
|---|---|
| Product # | CBP6140 |
| Pricing | 1 mg USD $100.0, 5 mg USD $300.0 |
| Source | Synthetic |
| Reactivity | H, M, R, B, Mk |
| Applications | BL |
| Delivery Time | Ship in 3 weeks |
| Form | Lyophilized powder |
| Gene Symbol | CYP2C8; CYP2C9; CYP2C18; CYP2C19 |
| Entrez Gene (Human) | 1562; 1558; 1559; 1557 |
| SwissProt (Human) | P10632; P11712; P33260; P33261 |
| Purity | >85% |
| Quality Control | The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. |
| Directions for Use | Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours. |
| Storage/Stability | Shipped at 4°C. Store at -20°C for one year. |
| Datasheet | http://www.cohesionbio.com/download/CBP6140.pdf |